Edgestream Partners, L.P. Ironwood Pharmaceuticals Inc Transaction History

Edgestream Partners, L.P.

  • $2.23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
BUY
$8.32 - $15.45 $2.47 Million - $4.58 Million
296,287 New
296,287 $2.58 Million
Q3 2023

Nov 14, 2023
SELL
$8.25 - $11.35 $75,396 - $103,727
-9,139 Reduced 15.85%
48,528 $467,000
Q2 2023

Aug 10, 2023
BUY
$10.1 - $11.6 $582,436 - $668,937
57,667 New
57,667 $613,000

Others Institutions Holding IRWD

# of Institutions
231
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $570M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Edgestream Partners, L.P. Portfolio

Follow Edgestream Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Edgestream Partners, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email